Advertisement

Opportunistische Infektionen des ZNS

  • J. Madlener
  • E. B. Helm
Chapter

Zusammenfassung

Nahezu alle opportunistischen Infektionen des ZNS bei HIV-Infizierten treten bei weit fortgeschrittenem Immundefekt auf; mit ihnen wird das Stadium »AIDS« erreicht. Es handelt sich um Infektionen mit Protozoen (besonders Toxoplasma gondii), Viren (CMV, JCV, VZV, HSV) oder Pilzen (Kryptokokken, Aspergillus spp.). Bakterielle Infektionen sind in Deutschland selten. An erster Stelle steht hier die Tuberkulose, gefolgt von atypischen Mykobakterien. Auch Listerien- und Meningokokken-Meningitiden sollen bei HIV-Infizierten häufiger als bei Immunkompetenten vorkommen, wobei diese beiden Erkrankungen nicht als AIDS-definierend gelten.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Carr A, Tindall B, Brew BJ, Marriott DJ, Harkness JL, Penny R, Cooper DA: Low-Dose Trimethoprim-Sulfamethoxazole Prophylaxis for Toxoplasmosic Encephalitis in Patients with AIDS. Ann Int Med 117: 106–111 (1992).PubMedCrossRefGoogle Scholar
  2. Clumeck N: Some Aspects of the Epidemiology of Toxoplasmosis and Pneumocystosis in AIDS in Europe. Eur J Clin Microbiol Infect Dis 10 (3): 1778 (1991).CrossRefGoogle Scholar
  3. Cohn JA, McMeeking A, Cohen W, Jacobs J, Holzmann RS: Evaluation of the Policy of Empiric Treatment of Suspected Toxoplasma Encephalitis in Patients with the Aquired Immunodeficiency Syndrome. Am J Med 86:52127 (1989).Google Scholar
  4. Dannemann BR, McCutchan JA, Israelski DM, Antoniskis D, Leport C, Luft BJ, Chiu J, Wilde JL, Nussbaum JN, Orellana M, Heseltine PLC, Leedorn JM, Clumeck N, Morlat P, Remington JS: Treatment of Acute Toxoplasmosis with Clindamycin. Eur J Clin Microbiol Infect Dis 10 (3): 193195(1991).CrossRefGoogle Scholar
  5. De Gans J, Portegies P, Reiss P, Troost D, van Gool T, Lange JM: Pyrimethamine alone as maintenance therapy for central nervous system toxoplasmosis in 38 patients with AIDS. J Acquir Immune Defic Syndr 5(2): 13742 (1992).Google Scholar
  6. Dina TS: Primary Central Nervous System Lymphoma versus Toxoplasmosis in AIDS. Radiologyl 79(3):823–828(1991).Google Scholar
  7. Enzensberger W, Helm EB, Hopp G, Stille W, Fischer P-A: Toxoplasmose-Enzephalitis bei Patienten mit AIDS. Dtsch. Med. Wochenschr. 110: 83–87 (1985).PubMedCrossRefGoogle Scholar
  8. Enzensberger W: Neuromanifestationen bei AIDS. Schwer Verlag, Stuttgart (1989).Google Scholar
  9. Fischer P-A, Enzensberger W: Neurological Complications in AIDS. J Neurol 234: 269–279 (1987).PubMedCrossRefGoogle Scholar
  10. Grant IH, Gold JWM, Rosenblum M, Niedzwiecki D, Armstrong D: Toxoplasma gondii Serology in HIV-infected Patients: the Development of Central Nervous System Toxoplasmosis in AIDS. AIDS 4(6): 519–521 (1990).PubMedCrossRefGoogle Scholar
  11. Haverkos HW: Assessment of therapy for toxoplasma encephalitis. Am J Med 82: 907–914(1987).PubMedCrossRefGoogle Scholar
  12. Jacobson MA, Besch CL, Child C, Hafner R, Muth K, Deyton L: Clinical Programs for Clinical Research on AIDS: Description of a Randomized Prospective Study of Clindamycin versus Pyrimethamine for Prevention of Toxoplasma gondii Infection. Eur J Clin Microbiol Infect Dis 10 (3): 195198(1991).CrossRefGoogle Scholar
  13. Katlama C: Evaluation of the Efficacy and Safety of Clindamycin Plus Pyrimethamine for Induction and Maintenance Therapy of Toxoplasmic Encephalitis in AIDS. Eur J Clin Microbiol Infect Dis 10 (3): 189191 (1991).CrossRefGoogle Scholar
  14. Leport C, Raffi F, Matheron S, Katlama C, Regnier B, Saimot AG, Marche C, Vedrenne C, Vilde JL: Treatment of Central Nervous System Toxoplasmosis with Pyrimethamine/Sulfadiazine Combination in 35 Patients with the Acquired Immunodeficiency Syndrome. Am J Med 84:94100 (1988).CrossRefGoogle Scholar
  15. Luft BJ, Fuhrer J: Toxoplasmic encephalitis. AIDS Clinical Review, New York: 21534 (1990).Google Scholar
  16. Luft BJ, Remington JS: Toxoplasmic Encephalitis in AIDS. Clin Infect Dis 15: 211–22(1992).PubMedCrossRefGoogle Scholar
  17. Parmley SF, Goebel FD, Remington JS: Detection of Toxoplasma gondii in Cerebrospinal Fluid from AIDS Patients by Polymerase Chain Reaction. J Clin Microbiol 30(11): 3000–3002 (1992).PubMedCentralPubMedGoogle Scholar
  18. Pedrol E, GonzalezClemente JM, Gatell JM, Mallolas J, Miro JM, Graus F, Alvarez R, Mercader JM, Berenguer J, Jimenez de Anta MT, Valls ME, Soriano E: Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy. AIDS 4: 511517 (1990).CrossRefGoogle Scholar
  19. Porter SB, Sande AM: Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 327(23): 1643–1648 (1992).PubMedCrossRefGoogle Scholar
  20. Tuazon CU: Toxoplasmosis in AIDS Patients. Journal of Antimicrobial Chemotherapy 23, Suppl. A.: 7782 (1989).CrossRefGoogle Scholar
  21. Wallace MR, Rossetti RJ, Olson PE: Cats and Toxoplasmosis Risk in HIV-infected Adults. JAMA 269(1): 76–77 (1993)PubMedCrossRefGoogle Scholar
  22. Weiss LM, Harris C, Berger M, Tanowitz HB, Wittner M: Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute toxoplasma encephalitis in patients with AIDS. J Infect Dis 157 (3): 580583 (1988).CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • J. Madlener
  • E. B. Helm

There are no affiliations available

Personalised recommendations